CD4 and hepatocellular carcinoma: As we found the CPT inhibitor perhexiline rescued murine CD4+ T cell and Jurkat cell apoptosis when cultured with C18:2 in vitro (Supplementary Fig. 4A,, B), we sought to test if perhexiline could rescue CD4+ T cells in vivo and subsequently decrease the incidence of HCC.